A randomized, double-blind, placebo-controlled 8-week trial of the efficacy and tolerability of multiple doses of Lu AA21004 in adults with major depressive disorder
Risk factors for inpatient suicide do not translate into meaningful risk categories-all psychiatric inpatients are high-risk